An initial study to determine the T lymphocyte response in seriously ill COVID-19 patients: An observational study in Pune, India
Not Applicable
Completed
- Conditions
- Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhereHealth Condition 2: B342- Coronavirus infection, unspecified
- Registration Number
- CTRI/2021/03/032028
- Lead Sponsor
- Dr D Y Patil Vidyapeeth Pune
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 137
Inclusion Criteria
Both male and female participants age of 18 years or greater from Pune region, and only who are laboratory confirmed by diagnostic Real-time RT-PCR test with the following features:
(1) hospitalized requiring supplemental oxygen.
(2) hospitalized requiring non-invasive ventilation or the use of high-flow oxygen devices.
(3) hospitalized receiving invasive mechanical ventilation or extracorporeal membrane oxygenation.
Exclusion Criteria
Study participants with other respiratory infections and with underlying infections will be excluded.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method T cell immune response in severely ill COVID-19 patients at 0 month, 1 month and 6 month time pointsTimepoint: At 0 month, 1 month and 6 month time points
- Secondary Outcome Measures
Name Time Method T cell immune response in severely ill COVID-19 patients at one month after recovery and at 6 months after recovery.Timepoint: 1 month and 6 months after recovery